BSAVA Clinical Abstracts | Submission Guidelines

Familiarise yourself with the Submission Guidelines below before submitting your abstract application for 2022 consideration.

Clinical Abstract | Format


Clinical Abstracts may be in the form of an oral or poster presentation.

The format for your abstract should follow that for submission of a paper for publication. The abstract is a concise structured summary - no more than 250 words (excluding title and declarations) - divided, under separate headings into Objectives, Methods, Results and Impact . Each section should address the questions given in the table below. The Summary should not contain non-standard abbreviations or acronyms.

The purpose of the abstract is to capture the interest of the reader, while accurately reflecting the content of the intended presentation or poster. 


Structure of Clinical Abstract

Title
The title should be precise and attention catching but should also describe what you are writing about

Objectives

What is the question that is being asked /answered?

Methods

What is the type of study? What is the study population? How was the data analysed?

Results

What were the findings?

Impact/ Clinical Significance

What are the implications and for whom?

A brief (2 sentence) statement explaining the impact of the work on small animal primary care or referral clinical practice.

Funding/ Declarations of Interest

Include details of any declarations

Format

Oral Presentations |


Oral presentations allow for a short 13–14-minute presentation of the material in the submitted abstract, plus 1-2 minutes for questions. Presenters are reminded that it is very important to stick within the time limit to ensure the next presenter may start in their allocated time.

The oral presentations will be live streamed to the virtual platform and recorded for the on-demand element of BSAVA Congress 2022.

Format

Poster Presentations | In Print


On-site posters must be size A0 (1.189m x 0.841m) in portrait format. The poster may include:

  • Figures & tables (within the above dimensions) in UK English and SI Units.
  • Must also display: title, authors & affiliations, references, and details of funding & conflicts of interest. Plus abstract headers: Objectives, Methods, Results & Impact.

Posters for the face-to-face element of Congress 2022 will be presented in the Exhibition Hall in a dedicated posters area.

Presenters must bring the poster of the above dimensions along, printed & ready to put up. Instructions will be provided.

In order to present a face-to-face poster, presenters should have a face-to-face event pass (see prices of attendance below) - we recommend purchasing your pass once you have been notified if you have been successful.

Format

Poster Presentations | Virtual


Virtual posters must be in portrait format.  The poster may include:

  • Figures & tables (within the above dimensions) in UK English and SI Units.
  • Must also display: title, authors & affiliations, references, and details of funding & conflicts of interest. Plus abstract headers: Objectives, Methods, Results & Impact.

The online platform for the Hybrid Congress 2022 has the facility for a virtual poster hall where the pdf of your poster is uploaded. Pre-recorded presentations can also be uploaded and included with this format.

In addition to this there is a facility for a text-based Q&A with the attendees. Instructions will be provided.

In order to present a virtual poster, you must have a virtual event pass (see prices below) - we recommend purchasing your pass once you have been notified if you have been successful.

Fees

Registration Fees for Presenting Authors | 

In order to present an oral or poster at Congress 2022, you must purchase a ticket to attend the relevant part of Congress. Successful Presenting Authors are entitled to purchase at a heavily discounted fee:


Ticket Type

Presenting Author Discounted Rate*

Details

Face-to-Face attendance

£170 +VAT

Allows full delegate access to Manchester Central & the virtual platform .

Entry includes: access to the lectures and exhibition hall at the face to face event, as well as full access to all live and pre-recorded content on the virtual platform during the live phase & during the 60-day on demand period.

Virtual attendance

£85 +VAT

Allows full delegate access to the virtual platform only .

Entry includes: ability to watch all the live sessions & participate in the Q&As in real-time as they are live streamed from Manchester onto the virtual platform. Access into the virtual exhibition hall and network lounges, as well as to all the pre-recorded content on the platform during the live phase & during the 60-day on demand period is also included.

* Disclaimer : The above rates are only available to authors of successful abstracts who are invited to present at Congress 2022.  We advise booking your place when you have received your confirmation to present (authors will be notified early 2022).

Submission rules |


  • DO NOT submit an abstract on behalf of another person.
  • Abstracts must be submitted using the abstract template which includes the headers: Objectives, Methods, Results, and Impact Statement.
  • The abstract must be submitted by the presenting author.
  • Abstracts must not exceed 250 words (excluding title and declarations of interest and author details).
  • The authors, and their place of work, should not be identified in the main text of the abstract.
  • The assessment process is blind and the abstracts must be anonymised on submission.
  • Abstracts submitted for consideration should not have been presented at other Congresses, nor published in journals before Congress. They can have been shown at local CPD events.
  • Abstracts must be written in U.K. English and using SI units.
  • All research presented must comply with UK legislation pertaining to animal welfare, ethics and data protection. Work performed outside the UK must still comply with the UK Veterinary Surgeons Act or should reasonably be expected NOT to require a UK Home Office license if performed in the UK. See information on ethics below.
  • Use of Trade names is not permitted in the abstract.
  • As a rule of thumb, diagrams and references are not acceptable in the abstract.
  • It’s the author’s responsibility to ensure that they have obtained permission for use of any copyright images or materials.

Clinical abstracts will be rejected without further scrutiny if they fail to comply with the submission rules or if they:

  • Are received after the closing date.
  • Do not follow the structured summary as detailed above.
  • Are considered too preliminary in nature or are deemed to be of low scientific quality.
  • Are not relevant to small animal veterinary practice or clinical science
  • Do not meet the ethical guidelines outlined above and/or do not have satisfactory ethical approval from the relevant regulatory bodies or are deemed to have caused unnecessary pain, distress, suffering, or lasting harm to animals.


Presentation Rules |


  • Submitting author should be first author.
  • First author must be presenting author.
  • The presentation must concentrate on the information contained in the abstract and in answering the questioned detailed in the table above.
  • Specific advertising of products by presenters must not occur.


Ethics |


Authors may find the RCVS / BVA Ethical Review Working Party Report helpful in fulfilling these requirements Authors are advised to consult Helen Field ( h.field@bsava.com ) if they are unsure about any of these regulations.